These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 2085334)

  • 1. Long-term multicentric study with azelastine in patients with intrinsic asthma.
    Ulbrich E; Nowak H
    Arzneimittelforschung; 1990 Nov; 40(11):1225-30. PubMed ID: 2085334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the safety and efficacy of multiple doses of azelastine to adult patients with bronchial asthma over time.
    Tinkelman DG; Bucholtz GA; Kemp JP; Koepke JW; Repsher LH; Spector SL; Storms WW; Van As A
    Am Rev Respir Dis; 1990 Mar; 141(3):569-74. PubMed ID: 2178521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind assessment of azelastine in the treatment of perennial allergic rhinitis.
    Grossman J; Halverson PC; Meltzer EO; Shoenwetter WF; van Bavel JH; Woehler TR; Freitag JJ; Hemsworth GR
    Ann Allergy; 1994 Aug; 73(2):141-6. PubMed ID: 8067597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and safety of salmeterol (50 microgram) and fluticasone (250 microgram) in a single inhaler device (diskus) in patients with mild to moderate asthma].
    Beeh KM; Beier J; Kornmann O; Wiewrodt R; Buhl R;
    Pneumologie; 2002 Feb; 56(2):91-7. PubMed ID: 11842346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared to placebo and budesonide.
    Dorow P; Aurich R; Petzold U
    Arzneimittelforschung; 1993 Aug; 43(8):909-12. PubMed ID: 8105785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
    Cass LM; Gunawardena KA; Macmahon MM; Bye A
    Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of inhaled Salmeterol (Serevent) as maintenance therapy for asthma in Nairobi.
    Odhiambo JA; Nganga LW; Gikonyo BM
    East Afr Med J; 1994 Feb; 71(2):88-92. PubMed ID: 7925051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.
    Busse WW; Casale TB; Murray JJ; Petrocella V; Cox F; Rickard K
    Am J Manag Care; 1998 Nov; 4(11):1579-87. PubMed ID: 10338904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal treatment of perennial allergic rhinitis. Comparison of azelastine nasal spray and budesonide nasal aerosol.
    Gastpar H; Aurich R; Petzold U; Dorow P; Enzmann H; Gering R; Köchy HP; Philippe A; Renz W; Wendenburg G
    Arzneimittelforschung; 1993 Apr; 43(4):475-9. PubMed ID: 8494580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial.
    Harnest U; Price D; Howes T; Sussman G
    J Asthma; 2008 Apr; 45(3):215-20. PubMed ID: 18415829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitussive effect of azelastine hydrochloride in patients with bronchial asthma.
    Shioya T; Ito N; Watanabe A; Kagaya M; Sano M; Shindo T; Miura S; Kimura K; Miura M
    Arzneimittelforschung; 1998 Feb; 48(2):149-53. PubMed ID: 9541725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical trial of the efficacy and safety of montelukast as monotherapy in patients with chronic stable bronchial asthma.
    Athavale A; Souza GA; Avasthi R; Singh NP; Kale M; Taneja A; Sireesha K
    J Indian Med Assoc; 2004 Feb; 102(2):109-11. PubMed ID: 15200214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis.
    Giede C; Metzenauer P; Petzold U; Ellers-Lenz B
    Curr Med Res Opin; 2000; 16(3):153-63. PubMed ID: 11191004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
    Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Taylor DR
    Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of action of a single dose of azelastine in patients with chronic asthma.
    Chervinsky P; Grossman J; Freitag JJ
    J Asthma; 1995; 32(2):141-5. PubMed ID: 7559264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of azelastine on the infiltration of inflammatory cells into the bronchial mucosa and clinical changes in patients with bronchial asthma.
    Hoshino M; Nakamura Y
    Int Arch Allergy Immunol; 1997 Nov; 114(3):285-92. PubMed ID: 9363911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.